Pediatric Lichen Sclerosus: A Review of the Epidemiology and Treatment Options.
Lichen sclerosus (LS) is a rare, chronic, inflammatory disease of the skin that primarily affects postmenopausal women but may occur in men and children as well. Approximately 7% to 15% of cases are believed to occur in children. The epidemiologic data for LS have been limited and treatment options are not well studied, particularly in children. We reviewed new developments available in the current literature on the epidemiology and management of LS for children.
David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, California.|Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts.
Lana X
LX
Tong
Department of Dermatology, Stanford University, Palo Alto, California.
Grace S
GS
Sun
Department of Dermatology, Stanford University, Palo Alto, California.
Joyce M C
JM
Teng
D000284:Administration, Oral; D000287:Administration, Topical; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D017677:Age Distribution; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D018459:Lichen Sclerosus et Atrophicus / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology*; D008297:Male; D011788:Quality of Life; D012176:Retinoids / Q000627:therapeutic use; D018570:Risk Assessment; D012720:Severity of Illness Index; D017678:Sex Distribution; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D012176:Retinoids